This site is intended for healthcare professionals

Seagen + Astellas announce Padcev pivotal EV 201 trial for previously treated advanced urothelial cancer for those ineligible for cisplatin chemotherapy.

Read time: 2 mins
Last updated:28th Jun 2021
Published:14th Feb 2021
Condition: Bladder Cancer
Type: drug
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest